Showing results (171-180 of 189) with videos related to

Sort By:
Pageof 19
Circulation. Heart Failure|September 30, 2025
Significance of Elevated Donor-Derived Cell-Free DNA in Heart Transplant Recipients With Negative Endomyocardial Biopsies: A Dawn of a New EraCathrine M Moeller, Andrea Fernandez Valledor, Daniel Oren, et al.
Journal of Cardiac Failure|June 25, 2025
Efficacy of Letermovir for Cytomegalovirus Prophylaxis in Heart Transplant Recipients with Moderate to High-Risk CMV SerostatusAfsana Rahman, Changhee Lee, Salwa Rahman, et al.
Clinical Transplantation|October 18, 2024
Clinical Utility of Donor-Derived Cell-Free DNA in Heart Transplant Recipients With Multi-Organ TransplantsCathrine M Moeller, Daniel Oren, Andrea Fernandez Valledor, et al.
Circulation. Heart Failure|February 22, 2023
A Composite Score Summarizing Use and Dosing of Evidence-Based Medical Therapies in Heart Failure: A Nationwide Cohort StudyNiklas Dyrby Johansen, Muthiah Vaduganathan, Deewa Zahir, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 30, 2025
Efficacy and safety of belatacept in heart transplant recipientsJulia Baranowska, Daniel Oren, Andrea Fernandez Valledor, et al.
JACC. Advances|April 22, 2026
Comparison of Microcirculation in Chronic Heart Failure, Cardiogenic Shock, LVAD, and Heart TransplantationJulia Baranowska, Andrea Fernandez Valledor, Cathrine M Moeller, et al.
JAMA Cardiology|March 23, 2022
Improving Enrollment of Underrepresented Racial and Ethnic Populations in Heart Failure Trials: A Call to Action From the Heart Failure CollaboratoryErsilia M DeFilippis, Melvin Echols, Philip B Adamson, et al.
Medrxiv : the Preprint Server for Health Sciences|July 9, 2024
Clinical Utility of the Molecular Microscope Diagnostic System in a Real-World Transplant Cohort: Moving Towards a New ParadigmAndrea Fernandez Valledor, Cathrine M Moeller, Gal Rubinstein, et al.
Blood Neoplasia|October 23, 2025
Posttransplant rituximab exposure and risk of PTLD in solid organ transplant recipients with EBV DNAemiaEvelyn H Orlando, Patrick Gould, Brian Cuzzo, et al.
Clinical Transplantation|October 14, 2025
Clinical Utility of Combined Donor-Derived Cell-Free DNA and Peripheral Gene-Expression-Profiling in Heart Transplant RecipientsCathrine M Moeller, Andrea Fernandez Valledor, Daniel Oren, et al.
Pageof 19